abstract Adverse allergic reactions due to the administration of the vaccines developed for
the protection of coronavirus disease 2019 (COVID-19) have been reported since the …

On December 10, 2020, the BBC reported two allergic adverse events following the first
injection of the BioNTech COVID-19 vaccine BNT162b2. Up to December 19, 2020, severe …

Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2,
several severe anaphylaxis cases occured within the first few days of public vaccination. An …

Background For the preventive treatment of the 2019 coronavirus disease (COVID-19) an
unprecedented global research effort studied the safety and efficacy of new vaccine …

The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …

Vaccines are essential public health tools with a favorable safety profile and prophylactic
effectiveness that have historically played significant roles in reducing infectious disease …

Vaccines against COVID-19 (and its emerging variants) are an essential global intervention
to control the current pandemic situation. Vaccines often cause adverse events; however …

Abstract Background When initiating the Danish vaccination program against COVID‐19, the
incidence of anaphylaxis was estimated to be 10 times higher compared to other virus …

COVID‐19‐related mortality in high‐risk individuals is substantial and current treatment
options are limited. There is convincing evidence that the COVID‐19 vaccines reduce the …

Conventional vaccines have been widely studied, along with their risk of causing allergic
reactions. These generally consist of mild local reactions and only rarely severe …